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EDITORIAL
A  new  form of fraud  in  scientific  publishing:
Supplanting or  hacking the  scientific  review  process
Biomedical  fraud  is  an unfortunate  reality,  and  one  with  seri-
ous  consequences,  in some  cases  terrible  ones.  For instance,
British  researcher  Dr.  Andrew  Wakefield  set  off scandal  and
fear  surrounding  the use  of  vaccination  against  measles,
mumps  and  rubella.  He  accomplished  this  through  a  publica-
tion  based  on  spurious  and corrupt  research.  Wakefield  was
sadly  known  for  fraudulent  research  published  in 1998,  sup-
porting  a  now  discredited  thesis.  The  thesis  claimed  there
was  a  link  between  the  administration  of  the  triple vac-
cine  --  measles,  mumps  and  rubella  --  and  autism,  as  well
as  intestinal  diseases.1
After  the  publication  of  his  article,  several  independent
researchers  tried  unsuccessfully  to  reproduce  his  findings,
with  the  sole  purpose  of confirming  the  hypothesis  linking
this  triple  vaccine  to autism  and  gastrointestinal  diseases.
In  2004,  research  revealed  the  existence  of  a financial  con-
flict  of  interests  on  Wakefield’s  behalf,  whereupon  most  of
his  co-authors  withdrew  their  support  to  the  interpretations
of  the  study.  Wakefield’s  study  led to  a decline in vaccination
rates  in  the  US,  the UK  and  Ireland,  and consequently,  a  rise
in  the  number  of cases  of  measles  and  mumps,  some  of  them
severe,  some  even  fatal.  His  continuous  warnings  against
vaccination  created  an atmosphere  of  mistrust  towards  all
vaccines,  thus  contributing  to  the  reappearance  of  other
diseases  which  were  thought  to  be  under  control.
Science  is a communitarian  enterprise  built  on  truth  and
trust.  The  referees  and  editors  who  review  and  study  arti-
cles  sent  for  publication,  usually  take  the data  at face  value,
and  assume  the  authors  obtained  and  analyzed  their  results
in  an  honest  manner.  Reviewers  are asked  to judge  whether
or  not  the  conclusions  are based  on  solid  data,  but  not judge
the  data  itself  or identify  whether  or  not  the  data  is  fraud-
ulent.  The  system  is  not established  to  work  in any  other
way;  if the  editors  and  referees  did not  trust  the  authors  and
assumed  each  result  could  potentially  be  fake,  few articles
would  be  published.  There  is  not enough  known  data  of  fraud
to  justify  the  cost  (time,  money  or  experimental  animals)
that  would  require  all  data  to  be  duplicated  by  independent
laboratories.
Nevertheless,  a  recent  article  published  by The  New
England  Journal  of  Medicine  pointed  our  attention  towards  a
new  form  of  fraud.2 Before  a biomedical  article  is  accepted
for  its  publication,  scientific  journals  sent the material  for
its  evaluation  in pairs  (peer review),  so experts  in the  area
could  criticize  it,  make suggestions  to  improve  it and  recom-
mend  to  the editors  whether  the  paper  should  be accepted
or  rejected.  An  author,  whose  article  is  rejected  by  a  jour-
nal,  should  not be discouraged  and usually  tries  to  publish
it  in different  journals  in descending  order  of  importance.
Judgement  is  time-consuming,  and it is  not uncommon  that
editors  of  journals  like  The  Lancet  or  the  New  England
Journal,  to  name  a few,  can  hardly  find  experts  in all
areas.  Editors  of  smaller  journals  do  not have the neces-
sary  resources  to  find these  experts;  moreover,  there  is  the
fact  that  editors  are  judged  on  their  speed  in responding
to  and publishing  these  manuscripts.  Scientists  are  always
anxious  to  publish  their  results  as  fast as  possible,  because
other  colleagues  in  their  field  may  publish  before  them.  This
competition  is  welcomed.  However,  it may  cause  problems,
unfair  competition,  corruption,  etc.
Because  of  this  super  specialization,  it is  becoming
increasingly  common  to  ask  the authors  of  these papers  to
suggest  referees  for  the  judging  process  of  their  own  work.
This,  of  course,  opens  the  possibility  of  fraud.  The  pres-
sure  of  academics  to  publish,  independently  of  whether  they
have  something  of  relevance  or  not,  to  advance  in  their  pro-
fessional  careers,  or  just  to  keep  their  reputation,  makes
easy  targets  for  dishonesty.
Recently,  two  major  scientific  journal  editorials,  Sage  and
Springer,  were forced  to  withdraw  over  100  articles  because
they  discovered  that  the  judging process  was  spurious.  In
August  2015,  Springer  withdrew  64  articles  from  10  dif-
ferent  journals  after  the editorial  department  discovered
‘‘spurious  electronic  addresses’’  and an internal  investiga-
tion  exposed  that  the judging  reports  had  been  fabricated.
In  other  words,  the researchers  ‘‘created  their  own  eval-
uation’’.  This  occurred  just months  after BioMed  Central,
an  open  access  publicist  also  owned  by  Springer,  withdrew
another  43  papers.  The  pressure  to  publish  is  significant  for
scientist  around  the world,  and  competition  for space  in  the
most  prestigious  journals  is  harder  than  ever  before.  A  rea-
son  for  this  is  the  fast-growing  research  and  the number
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of  scientists  in developing  countries,  such as  Brazil,  India,
Turkey  and  China.  When  the gratification  of  publishing  is
also  high  (academic  promotion,  money)  this makes  taking
the  ‘‘easy  road’’  or  shortcuts  to  get  their  work  published
more  desirable.
This  circumstance  alerts us,  as  an editorial  group in
‘‘Medicina  Universitaria’’,  to  the new  form  of fraud.  Luckily,
in  our  judging  process,  authors  are not  allowed  to  suggest
experts.  Also,  this  is  done  in a blind  way,  thus  preventing
this  form  of  fraud  from  happening.
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